| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel
2 companies
Lee Chan Henry serves as a SVP, General Counsel at BEIGF and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 45 sells.
Historically, Lee Chan Henry's trades have earned a below-average insider score of 49/100 across 21 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -25.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | BEIGF Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 341 | $300.00 | $102,300.00 | - | - | - | |
| Feb 4, 2026 | ONC Beone Medicines AG | SVP, General Counsel | Sale+OE10b5-1 | 1,660 | $349.52 | $580,196.56 | - | -15.5% | - | |
| Jan 7, 2026 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sale+OE10b5-1 | 664 | $331.76 | $220,288.64 | - | -9.0% | - | |
| Dec 11, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sale+OE10b5-1 | 664 | $321.64 | $213,568.96 | - | -6.8% | - | |
| Nov 12, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sale+OE10b5-1 | 996 | $349.17 | $347,770.00 | - | -6.4% | - | |
| Oct 8, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sale+OE10b5-1 | 10,671 | $350.40 | $3,739,107.61 | - | -8.8% | -0.3% | |
| Sep 10, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sale+OE10b5-1 | 10,006 | $325.53 | $3,257,288.87 | - | +1.5% | +8.9% | |
| Aug 13, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sale+OE10b5-1 | 11,013 | $300.45 | $3,308,877.31 | - | +11.8% | +15.8% | |
| Jul 30, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sell | 920 | $304.60 | $280,232.74 | -100% | +5.6% | - | |
| Jun 16, 2025 | ONC Beone Medicines Ltd. | SVP, General Counsel | Sell | 422 | $266.50 | $112,463.00 | -100% | +25.7% | +0.0% |